African Pioneer Share Discussion Threads

[currypasty] 08/9/2006 14:18

will it break 39p this time ?

[ltinvestor] 07/9/2006 16:49

Very serious buying ahead of figures.

[currypasty] 04/9/2006 16:28

they suggest following the directors lead, and buy !!

[the prophet] 04/9/2006 15:44

-yes they were, in techinvest, described as a high growth low risk investment

[ltinvestor] 04/9/2006 15:40

Todays volume suggests that they must have been tipped?

[currypasty] 04/9/2006 13:43

34.0 - 36.0

cnks still on the ask

[tiltonboy] 04/9/2006 12:59

CURRY,

I've averaged up in the last half hour. Bought the shares of Cenkos, who are the new brokers, but it didn't change the price. Disappointing to see, when a new broker plonks himself on the offer.

I'm sure the problems ISOFT are having won't do ASP any harm.

tiltonboy

[currypasty] 04/9/2006 12:50

looking very strong at the moment

[currypasty] 21/8/2006 07:53

RNS Number:8618H
Ascribe plc
21 August 2006


For immediate release

Ascribe plc



Appointment of Nominated Adviser and Broker



Ascribe plc announces that Cenkos Securities Limited has been appointed as its
Nominated Adviser and Broker with immediate effect.

[tiltonboy] 09/8/2006 12:21

Interesting to see Sage acquiring Emdeon Practice Services in the US. Emdeon software is used in practice management and in the maintenance of patient data.

Hopefully it might ignite ASP at some stage.

tiltonboy

[currypasty] 04/7/2006 12:46

25k buy, at a penny over the ask

[currypasty] 03/7/2006 14:00

nice tick up today

[currypasty] 30/6/2006 07:45

RNS Number:4354F
Ascribe plc
30 June 2006





Ascribe plc ("Ascribe" or "the Group")

Ascribe acquires Patient Administration System ("PAS") supplier HE Information
Systems Limited ("HEIS") for #6.492 million


Ascribe (AIM:ASP), the health IT Group, today announces further expansion of
their offering with the acquisition of HE Information Systems, the supplier of
the CaMIS clinical and information management system to the UK National Health
Service. HEIS provides software to 21 hospitals within the NHS, many of which
also use Ascribe's Pharmacy or Accident & Emergency systems.

The total consideration of #6.492 million is to be satisfied by:

* On completion
- #2.994m of cash
- #0.998m to be satisfied by the issue of 3,326,666 shares in the
ordinary capital of Ascribe

* Deferred for up to 3 years
- #1.25m of cash
- #1.25m to be satisfied by the issue of shares in the ordinary capital
of Ascribe

In the year ended 31 March 2005, HEIS made a profit before tax of #0.52m on a
turnover of #2.5m. The value of the net assets being acquired is estimated at
approximately #1.15 million. The Board expects that this acquisition will be
earnings enhancing during the first year.

This acquisition marks a step change for the Group. The HEIS "PAS" product
provides a strategic offering in the Patient Administration System "PAS" and
secondary care, electronic patient record "EPR" markets. The management will
join the Ascribe team, allowing the Group to restructure its efforts in line
with the opportunities offered by the delays in the National Programme.

Due to personal circumstances, Graham Lewis will resign from the Board with
effect from 31 July 2006. The Board wishes him well for the future. Stephen
Critchlow will assume the role of CEO and Chairman as the Board focuses on
consolidating the Group and optimising the management team with some key
additions coming from HEIS.

Ascribe recently issued a positive trading update and is pleased to report that
trading continues to be in line with expectations.

Ascribe has today applied to AIM for admission of the 3,326,666 initial
consideration shares, which is expected to become effective on Thursday 6 July
2006.

Commenting, Stephen Critchlow, Executive Chairman of Ascribe, said: "This
acquisition positions Ascribe firmly as a leading health IT solutions provider
across primary and secondary care. HEIS has an excellent and highly
complementary product and will also bring a strong, experienced management team
to the Group. We will now be able to drive organic growth from a complete
product set created from best of breed applications. Any future acquisitions
will only follow once the Group is aligned to this significant opportunity."

[currypasty] 29/6/2006 17:02

RNS Number:4125F
Ascribe plc
29 June 2006


Ascribe plc (the "Company")


Holding in Company



The Company was informed on 27 June 2006 by Artemis Investment Management
Limited ("Artemis") that Artemis and certain of its subsidiaries are interested
in 9,789,376 ordinary shares of 1p each in the Company ("Ordinary Shares"),
representing 8.83 per cent. of the Company's current issued ordinary share
capital.

[ltinvestor] 19/6/2006 14:07

Main uk quoted beneficiary of Isofts demise

[currypasty] 19/6/2006 13:56

strong recovery today

[currypasty] 16/6/2006 17:37

RNS Number:7674E
Ascribe plc
16 June 2006


Ascribe plc (the "Company")
Holding in Company


The Company has been informed by Barclays plc ("Barclays") that through its
legal entity, Gerrard Limited, Barclays is interested in 5,463,439 ordinary
shares of 1p each in the Company ("Ordinary Shares"), representing 4.93 per
cent. of the Company's current issued share capital.


16 June 2006

[currypasty] 13/6/2006 15:10

RNS Number:5091E
Ascribe plc
13 June 2006


Ascribe plc (the "Company")

Director Shareholding


The Company was today informed that Jeremy Lee, a director of the Company, today
purchased 34,222 ordinary shares of 1p each in the Company ("Ordinary Shares")
at 28.5p each. Following this purchase Mr Lee is interested in 62,000 Ordinary
Shares representing 0.06% of the Company's current issued share capital.


13 June 2006

[currypasty] 06/6/2006 16:09

the market didnt like that last aquisition

[currypasty] 11/5/2006 07:41

RNS Number:7934C
Ascribe plc
11 May 2006



Ascribe plc ("Ascribe" or "the Group")

Ascribe acquires health division ("Jade Health") of Jade Software Corporation
("Jade") for up to #3.38 million.

Strategic partnership includes purchase of IP, customer contracts & goodwill



Bolton, UK (May 11th 2006) - Ascribe (AIM:ASP), the health IT Group, announces
today an important strategic move and expansion of its offering in the mental
health and Australasian markets with the acquisition of Jade Health, and a
strategic commitment with Jade Software Corporation to ensure the long-term
application development and maintenance of support contracts. Jade Health
provides IT solutions to 24 hospitals and health service organisations in New
Zealand, Australia and the UK.



Under the terms of the agreement, Ascribe's subsidiary Protechnic Exeter Ltd has
acquired the Jade Health business for a total consideration of #3.38 million
plus an additional sum in respect of the apportioned current assets and
liabilities at the date of completion. The initial consideration of #2.73
million is to be satisfied by #1.5m in cash and #1.23m by the issue of 3,804,516
new ordinary shares in Ascribe plc. In addition, a deferred consideration of up
to #0.65m is payable, approximately 14 months after completion, subject to the
business achieving certain sales and profit targets. Jade will continue to
support the business through long-term application support and development
contracts to ensure not only an effective transition of ownership but also
Ascribe's on-going access to skills and technology.



In the year ended 31 December 2005, Jade Health recorded a profit before tax of
approximately #0.3m on sales of approximately #2.3m. The value of the net assets
being acquired is estimated at approximately #0.1m. The business being acquired
has offices in Melbourne and Sydney. The Board of Ascribe expects that this
acquisition will be earnings enhancing during the first year.



In line with this announcement, Ascribe has recruited Bryn Evans as Chief
Executive Officer of its Asia Pacific region. Bryn has over 15 years experience
in managing and providing consulting services for information systems in the UK
and Australian health sectors. Bryn will be based in Sydney, where for a number
of years he was CIO of South Eastern Sydney Area Health Service. In the early
90s he was also Director of Finance and Information Systems at a large NHS
hospital in UK. As an independent consultant Bryn has undertaken numerous major
IT projects for health services in different states of Australia, and in the
Middle East. These have comprised consultancies for private sector and public
health service providers, and government departments in NSW, Victoria,
Queensland, and the Commonwealth Government of Australia, and also in New
Zealand.



Ascribe has today applied to AIM for admission of the 3,804,516 initial
consideration shares, which is expected to become effective on Tuesday 16 May
2006.



Commenting, Stephen Critchlow, Executive Chairman of Ascribe plc, said:
"Expanding Ascribe's customer base internationally is a central part of the
Group's strategy. Acquiring Jade Health significantly increases the critical
mass of the Group in the Australasian market where Ascribe already provides
hospital pharmacy software solutions to four of the eight Australian
jurisdictions and to 20% of the New Zealand public hospital market. Jade
Health's market leading position and brand recognition creates an exciting
opportunity for Ascribe to leverage its expanded portfolio of health solutions
to the Australasian markets."

[currypasty] 15/3/2006 08:32

15 March 2006


Ascribe plc ("Ascribe" or "the Group")

Interim results for the 6 months ended 31 December 2005

Ascribe plc (AIM:ASP), the health IT group, reports its interim results for the
6 months ended 31 December 2005.

Highlights

* Turnover increased 176% to #4.5m (2004: #1.6m)
* Like for like sales increased by 20% (2004: #3.8m)
* Maintenance revenue represents 62% of total turnover
* Operating profit before goodwill and share based payments grew to #0.98m
(2004: #0.03m)
* Operating profit grew to #0.67m (2004: loss: #0.02m)
* Adjusted EPS increased to 0.75p (2004: 0.06p)
* Completed acquisition of Barwick Systems Limited
* Strengthened market position as major supplier to UK NHS of Pharmacy,
Mental Health and Community Care and A&E IT solutions

Commenting on the results, Stephen Critchlow, Executive Chairman said: "This
excellent result for the first half of the year supports our strategy of
delivering real benefit for healthcare customers worldwide. Our customers work
to provide patient benefit on a daily basis with our systems, where
implementation delivers real savings and improvements in patient care. This is
delivering sustainable growth in a market that has an increasing demand for
clinical systems."

Graham Lewis, Chief Executive Officer added: "The first six months of this
financial year have been very successful for Ascribe. As we advised the market
in January, trading has been in line with expectations and the half year results
demonstrate the growth in revenues and profitability. The acquisitions that we
have made since the flotation on AIM have proved to be successful for all the
reasons that the Board identified before the acquisitions. The Board is
actively working on growing the core business organically and through further
acquisitions. We remain confident in our strategy and approach to the market."

[ltinvestor] 15/3/2006 08:15

Excellent set of results which should lead to a rerating of this company.It is no wonder Artemis have been increasing their holding and I expect other institutions to stake build over the coming months.